Biocat 2017 Presentation

1. #InformeBiocatbiocat.cat #InformeBiocat
informe.biocat.cat @biocat_cat
#InformeBiocat
In collaboration with:

2. #InformeBiocatbiocat.cat #InformeBiocat
INNOVATION IN
H E ALT H C AR E
COMPANIES / INDUSTRY
R E S E AR C H HEALTH & SOCIAL IMPACT
2025
BIOCAT REPORT: INNOVATION IN THE CATALAN LIFE
SCIENCES AND HEALTHCARE SECTOR
2010

3. #InformeBiocatbiocat.cat #InformeBiocat
€31,087 M 7.2%
+223,000
Jobs
7%
29.5%
of jobs
CATALAN LIFE SCIENCES & HEALTHCARE OUTLOOK
€17,802 M
Industry
per year of GDP
of Spanish expenditure on
biotech R&D activities

4. #InformeBiocatbiocat.cat #InformeBiocat
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
1,060
1,032
1,017
968
934
892
851
804
750
723
683
648
609
1
New company
per week
+53,700
Jobs
Source: Biocat (The graphic only shows active companies)
EVOLUTION OF THE COMPANIES IN THE BIOREGION OF
CATALONIA (2005 – 2017)

5. #InformeBiocatbiocat.cat #InformeBiocat
In the first semester of 2018,
17 multinationals announced
new innovation set-ups in
Catalonia.
CATALONIA: A GROWING INNOVATION HUB IN EUROPE

6. #InformeBiocatbiocat.cat #InformeBiocat
KEY SECTOR PLAYERS AT A WALKING DISTANCE

7. #InformeBiocat#InformeBiocatbiocat.cat #InformeBiocat
S W E D E N
382
333
252 248
190
140
101
0
100
200
300
400
500
SWE DEN AUS BEL CAT FIN IR
CATALONIA IS CURRENTLY ONE OF THE LEADING
SCIENTIFIC HUBS IN EUROPE
Sources: AGAUR (2007-March 2018);Web of Science (2013-2017)
CATALONIA
IRELAND
AUSTRIA
DENMARK
FINLAND
BELGIUM
304 290 280
208
181
156
89
0
100
200
300
400
SWE BEL CAT AUS DEN FIN IR
ERC Grants
Nature + Science

8. Source: Biocat
Stock Market
Public
VC Investment
Co-Development or
Collaboration agreements
Total
FINANCE RAISED IS ON UPWARD TREND, ESPECIALLY
REGARDING PRIVATE INVESTMENT (in M€)
#InformeBiocat
2011 2012 2013 2014 2015 2016 2017 2018
9.8
28.6
56.5
60.9
56.3
40.4
107.3
100.2
36.2
164.3
65.4
8.8
21.9
85.8
16.3
9.2
(October 2018)
biocat.cat
Investment that
creates value

9. #InformeBiocatbiocat.cat #InformeBiocat
INTERNATIONAL INVESTORS ARE INCREASING
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
10 1 1 1
5
6
14
22
37
50
50
International
investors
Source: Biocat
(x10 in just 5 years)
United States
Netherlands
Belgium
France
Switzerland
Austria
Germany
Japan
Russia
United Kingdom
Norway
Mexico
Luxembourg
Italy
Israel
Ireland
Canada
China

10. #InformeBiocatbiocat.cat #InformeBiocat
SUCCESS STORIES IN FUNDRAISING
€11-50 M
Invested
€1-10 M
Invested
2015 2016 2017 2018
Source: Biocat

11. #InformeBiocat
MOVING CUTTING EDGE SCIENCE TOWARDS PATIENTS
Source: Biocat and clinicaltrials.gov
18 new therapies
developed by
new companies

12. #InformeBiocatbiocat.cat #InformeBiocat
THE LAST 10 MONTHS IN THE BIOREGION

13. #InformeBiocatbiocat.cat #InformeBiocat
LIFE SCIENCES VENTURE FINANCING (M€) BY COUNTRY
(2000-2017)
Source: Crunchbase a n d Biocat
FINLAND CATALONIA AUSTRIA DENMARK BELGIUM SWEDEN IRELAND
1,778.8
1,034.5
289.2
1,491.3
1,125.5
592.8
483.5

14. #InformeBiocatbiocat.cat #InformeBiocat
VISION 2025

15. #InformeBiocatbiocat.cat #InformeBiocat
YEARLY INVESTMENT IN INNOVATIVE EMERGENT LIFE
SCIENCES COMPANIES
INTERNATIONAL INVESTORS INVESTING IN BIOREGION
STARTUPS
PRODUCTS IN CLINICAL DEVELOPMENT (THERAPIES)
CATALONIA: MOST INNOVATIVE LIFE SCIENCES HUB IN
EUROPE
Current 2025
130
M€/year
500
M€/year
50
18
#5
+100
50
#3
Source:Biocat
BUILDING THE FUTURE BY LEVERAGING THE BIOREGION
OF CATALONIA’S POTENTIAL

16. #InformeBiocatbiocat.cat #InformeBiocat
RECOMMENDATIONS (VISION 2025)
1. Basic research & Knowledge Transfer
2. Proof of concept testing
3. Potential for clinical trials
4. Attract talent
5. Fiscal and finance
6. Foster ecosystem strategy

17. #InformeBiocatbiocat.cat #InformeBiocat
@biocat_cat
In collaboration with:
#InformeBiocat informe.biocat.cat
Many hubs start-up…
just a few scale-up